Skip to main content
. 2017 Sep 21;8(50):88189–88198. doi: 10.18632/oncotarget.21112

Figure 3. Effects of aliskiren on cardiovascular mortality in randomized controlled trials of heart failure with reduced ejection fraction patients.

Figure 3